
Private Equity Spotlight
266 episodes — Page 6 of 6

S1 Ep 17Everything you wanted to know about preferred equity
Preferred equity isn’t new but firms such as 17Capital have been applying it to private equity via dedicated funds. In this 26-minute podcast we speak to managing partner Augustin Duhamel about the strategy that is quietly taking the market by storm.

S1 Ep 16Top 10 litigation risks facing PE firms today
Proskauer’s Josh Newville and Tim Mungovan talk through the key legal risks facing private equity in 2019.

S1 Ep 15What’s in your fund fee documents?
Private credit might be the new kid on the block in the alternative asset world, but the asset class’s fees have still evolved independently of private equity.

S1 Ep 14How Germany has become a 'battleground'
Hans-Jorg Baumann, Alexander Bode and Boerge Grauel discuss competition, supply and demand, bank domination and LP allocation priorities at the PDI Germany Forum 2019.

S1 Ep 13Leapfrog’s CEO on separating the impact investing wheat from the chaff
Fresh from raising a $700m fund in May, Leapfrog Investments’ founder and CEO Andy Kuper talks to Toby Mitchenall about how impact investing will evolve as more firms enter the fray.

S1 Ep 12How to avoid pitfalls in stapled deals
Blue chip managers are using stapled secondaries deals to boost fundraising and provide liquidity to LPs. In this episode, lawyers from Proskauer, Debevoise & Plimpton and MJ Hudson discuss how GPs and LPs should approach this increasing transaction type.

S1 Ep 11Gazing into the future: 5 tips for long-term investors
Wired contributing editor and futurist Ben Hammersley explains how to deal with exponential growth, discusses the needs created by new technology and explains why cognitive-enhancing infra is a must in the age of AI.

S1 Ep 10BC Partners on moving from PE into credit and real estate
BC Partners' Nikos Stathopoulos gives us a run down on what it is like making the move from private equity into private credit and real estate, in this 10-minute podcast.

S1 Ep 9Is this the most dangerous man in private equity?
Professor Ludovic Phalippou of Oxford University says GPs must accept that some elements of the PE model are not working so well for LPs. Is he a threat to the industry or its saviour?

S1 Ep 8Riverside on the GFC's 'difficult blessing'
As the firm celebrates 30 years in the industry, co-founder Bela Szigethy reflects on how the global financial crisis changed the firm for the better. PEI's Isobel Markham reports.

S1 Ep 7Why investors should look beyond the headlines in emerging markets
Albright Capital’s Gregory Bowes discusses why improvements in creditor rights and bankruptcy codes in emerging markets mean investors needn’t be weary of the asset class. PEI's Isobel Markham reports.

S1 Ep 6Highway to the opportunity zone
PERE's Lisa Fu talks with several experts to break down the opportunities, risks and rules that come with the new US federal program creating buzz among real estate investors.

S1 Ep 5Why the ‘triple whammy’ of issues impeding Chinese investments into US is here to stay
From capital controls and CFIUS to the intensifying trade war, Chinese investors trying to invest in the US are encountering many hurdles. David Blumenfeld and Paul Guan of the law firm Paul Hastings discuss these hurdles with PERE's Arshiya Khullar.

S1 Ep 3Where are hurdle rates trending?
With managers increasingly putting pressure on LPs to enter the carry early, Threadmark partner Patricia Wilkinson and PEI senior editors Bruno Alves, Jonathan Brasse and Toby Mitchenall look across asset classes to find out whether the status quo really is changing.

S1 Ep 3The smartest ways for debt firms to use technology
Are fund managers missing a trick by applying old-fashioned methods to data mining, deal sourcing and investor reporting? We dive into the issues in this 20-minute discussion with Matthias Kirchgaessner of Plexus and Alex Schmid of ESO Capital.

S1 Ep 2Why GP-led secondaries is the next big thing in private equity
From stapled deals to restructurings, tender offers to strip sales, Andrew Sealey, managing partner and chief executive of Campbell Lutyens, discusses the different types of GP-led deals and how they can benefit all parties.